Intervention

Trastuzumab + Pertuzumab

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting2

Common conditions2

Lead sponsors shown2

Clinical trials

2 shown

Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast CancerNCT07616427 · 2026-05-20

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast CancerNCT07057427 · 2025-06-24

Common conditions

Breast Cancer1 HR+/HER2+ Early Breast Cancer1

Leading sponsors

Henan Cancer Hospital1 Second Affiliated Hospital, Zhejiang University, School of Medicine1

Trial status mix

RECRUITING2

Phase mix

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.